SmartTab to Present at the 11th Annual BioNJ BioPartnering Virtual Conference

By Sacha Heppell - May 04, 2021

TRENTON, NJ—SmartTab, a leading drug delivery technology startup, will present at BioNJ's 11th Annual BioPartnering Conference—exploring their experience with patient-centered remote drug delivery. The conference brings together life sciences experts and professionals from across the Northeast and beyond for 1-1 partnering meetings, company presentations, startup pitches and plenary sessions. SmartTab’s Founder and CEO, Robert Niichel, will explore the novel ingestible drug delivery technology platform and the importance of their successful preclinical proof of concept study.

SmartTab is boldly combining wireless ingestible technology with active ingredient delivery. They’re pioneering pharmaceutical delivery technologies that could transform the way we take medication. SmartTab has two products that will soon be life-changing for millions of patients suffering from Crohn’s Disease and other gastrointestinal diseases: TargetTab™—a pill that you can tell when and where it releases medication in your body and InjectTab™—a pill to deliver biologics and large molecule without a visit to the doctor.

Website: BioNJ’s 11th Annual BioPartnering Conference

Event Dates: Tuesday, May 18 – May 19  

"We're thrilled to present at BioNJ's Eleventh Annual BioPartnering Conference because SmartTab’s commitment to patients and the healthcare industry extends beyond the lab. We believe in advocating, listening and partnering with patients and industry experts to improve drug delivery.”—Robert Niichel, CEO & Founder, SmartTab

With the importance of academic and industry collaboration in driving medical innovation forward, attendees will hear from and have the opportunity to meet with Columbia Technology Ventures, Coriell Institute for Medical Research, Johns Hopkins Technology Ventures, New Jersey Institute of Technology, New York University, Princeton University, Rowan University, Rutgers, The State University of New Jersey, Stevens Institute of Technology, University of Pennsylvania and The Wistar Institute.

About Veloce Corporation (SmartTab)

SmartTab is on a mission to advance digital drug delivery systems for effective therapies that improve patient outcomes. A patient-centered wireless drug delivery platform comprised of an ingestible capsule with a microprocessor, proprietary smart polymer actuator, and active ingredients. Starting with TargetTab for precise targeted drug delivery to the colon and then InjectTab, a biologics delivery system, making needles and syringes a thing of the past.


PodcastCoverForFeature

WHO WOULD HAVE THOUGHT

Listen and Subscribe to the Podcast

The perspectives of digital health thought leaders today and an inquiry into digital technologies of tomorrow.

Listen Now